Correction: Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study.

Autor: Zambrano B; Global Clinical Development Strategy, Sanofi, Montevideo, Uruguay., Peterson J; J. Lewis Research, Salt Lake City, UT, USA., Deseda C; Caribbean Travel Medicine Clinic, San Juan, Puerto Rico., Julien K; J. Lewis Research Inc, South Jordan, UT, USA., Spiegel CA; Craig A. Spiegel, MD Bridgeton, Bridgeton, MO, USA., Seyler C; Pediatric Clinical Trials Tullahoma, Tullahoma, TN, USA., Simon M; Michael W. Simon, MD, PSC, Lexington, KY, USA., Hoki R; Wee Care Pediatrics, Layton, UT, USA., Anderson M; Tanner Clinic, Layton, UT, USA., Brabec B; Midwest Children's Health Research Institute, Lincoln, NE, USA., Áñez G; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA., Shi J; Global Biostatistical Sciences, Sanofi, Swiftwater, PA, USA., Pan J; Global Biostatistical Sciences, Sanofi, Swiftwater, PA, USA., Hagenbach A; Sanofi, Marcy L'Étoile, France., Von Barbier D; Sanofi, Swiftwater, PA, USA., Varghese K; Global Clinical Immunology, Sanofi, Swiftwater, PA, USA., Jordanov E; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA., Dhingra MS; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA. MandeepSingh.Dhingra@sanofi.com.
Jazyk: angličtina
Zdroj: Pediatric research [Pediatr Res] 2024 Mar; Vol. 95 (4), pp. 1159.
DOI: 10.1038/s41390-023-02835-4
Databáze: MEDLINE